Proprio announces strategic partnership with Biedermann to “revolutionise” spine surgery
Proprio has announced a “landmark” multi-phase partnership with the Biedermann Group—an innovator in next-generation spinal implant systems and procedural solutions. Initially, the companies will...
SpineX closes recruitment for trial evaluating Scone SCS technology in neurogenic bladder
SpineX has closed recruitment for the CONTINENCE clinical trial of its proprietary Scone device. The study began back in May 2022 and is evaluating...
Orthobond secures US FDA nod for antibacterial surface treatment applied to a spinal device
Orthobond Corporation has announced that the US Food and Drug Administration (FDA) recently granted its de novo marketing request for the use of Ostaguard—its...
Medcura closes US$22.4 million in financing to boost surgical haemostasis portfolio
Medcura has announced that it has closed a private placement with aggregate gross proceeds of US$22.4 million in convertible debt. The company intends to use the...
